A spectral phenotype of oncogenic human papillomavirus-infected exfoliative cervical cytology distinguishes women based on age

Clinica Chimica Acta

Volumn 411, Issue 1-16, 2010, Pages 1027-1033

  Kelly, Jemma G ^a   Cheung, Karen T ^a   Martin, Cara ^b   O'Leary, John J ^b   Prendiville, Walter ^b   Martin Hirsch, Pierre L ^a,c   Martin, Francis L ^a  

^a LANCASTER UNIVERSITY   (United Kingdom)

^b Pathology Research Laboratory   (Ireland)

^c LANCASHIRE TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Exfoliative cervical cytology; Human papillomavirus; Infrared spectroscopy; Multivariate analysis; Persistent infection

Indexed keywords

AMIDE; AMIDE I; AMIDE III; CARBOHYDRATE; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER GRADING; CELL DIFFERENTIATION; CELL IMMORTALIZATION; CONDYLOMA; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; FEMALE; GENOTYPE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 68; INFORMATION RETRIEVAL; INFRARED SPECTROSCOPY; MAJOR CLINICAL STUDY; PHENOTYPE; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; WART VIRUS;

ADULT; AGE FACTORS; AGED; AGING; CELL LINE, TUMOR; CERVIX UTERI; DISCRIMINANT ANALYSIS; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PHENOTYPE; PRINCIPAL COMPONENT ANALYSIS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; YOUNG ADULT;

HUMAN PAPILLOMAVIRUS;

EID: 77953285422     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.03.029     Document Type: Article

References (23)

1. Bosch F.X., Iftner T. The aetiology of cervical cancer. NHSCSH publication no. 22 2005.
2. Collins S., Mazloomzadeh S., Winter H., et al. High incidence of cervical human papillomavirus infection in women during their first sexual relationship. BJOG 2002, 109:96-98.
3. Wentzensen N., Klug S.J. Early detection of cervical carcinomas: finding an overall approach. Dtsch Arztebl Int 2008, 105:617-622.
4. Stanley M. Immune responses to human papillomavirus. Vaccine 2006, 24:S16-S22.
5. 10-INNO LiPA human papillomavirus (HPV) genotyping test and the roche linear array HPV genotyping test. J Clin Microbiol 2006, 44:3122-3129.
6. Woodman C.B.J., Collins S.I., Young L.S. The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer 2002, 7:11-22.
7. Kyrgiou M., Shafi M. HPV vaccine. Obstet Gynaecol Reprod Med 2008, 19:26-28.
8. Lepique A.P., Rabachini T., Villa L.L. HPV vaccination: the beginning of the end of cervical cancer?. Mem Inst Oswaldo Cruz 2009, 104:1-10.
9. Zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002, 2:342-350.
10. Snijders P.J.F., Steenbergen R.D.M., Heideman D.A.M., Meijer C.J.L.M. HPV-mediated cervical carcinogenesis: concepts and clinical implications. J Pathol 2006, 208:152-164.
11. Stevens M.P., Garland S.M., Rudland E., Tan J., Quinn M.A., Tabrizi S.N. Comparison of the digene hybrid capture 2 assay and roche amplicor and linear array human papillomavirus (HPV) tests in detecting high-risk HPV genotypes in specimens from women with previous abnormal Pap smear results. J Clin Microbiol 2007, 45:2130-2137.
12. Stuart B. Infrared spectroscopy: fundamentals and applications 2005, John Wiley and Sons Inc, Chichester, England. 1st ed.
13. Walsh M.J., German M.J., Singh M., et al. IR microspectroscopy: potential applications in cervical cancer screening. Cancer Lett 2007, 246:1-11.
14. Walsh M.J., Singh M.N., Pollock H.M., et al. ATR microspectroscopy with multivariate analysis segregates grades of exfoliative cervical cytology. Biochem Biophys Res Commun 2007, 352:213-219.
15. Kelly J.G., Angelov P.P., Walsh M.J., et al. Intelligent interrogation of mid-IR spectroscopy data from exfoliative cervical cytology using self-learning classifier eClass. Int J Comput Intel Res 2008, 4:392-401.
16. Wood B.R., Chiriboga L., Yee H., Quinn M.A., McNaughton D., Diem M. Fourier transform infrared (FTIR) spectral mapping of the cervical transformation zone, and dysplastic squamous epithelium. Gynecol Oncol 2004, 93:59-68.
17. Martin F.L., German M.J., Wit E., Fearn T., Ragavan N., Pollock H.M. Identifying variables responsible for clustering in discriminant analysis of data from infrared microspectroscopy of a biological sample. J Comput Biol 2007, 14:1176-1184.
18. Smotkin D., Wettstein F.O. The major human papillomavirus protein in cervical cancers is a cytoplasmic phosphoprotein. J Virol 1987, 61:1686-1689.
19. Münger K., Howley P.M. Human papillomavirus immortalization and transformation functions. Virus Res 2002, 89:213-228.
20. - modifications as a marker of the putative stem cell region of human intestinal crypts. Stem Cells 2008, 26:108-118.
21. Walsh M.J., Hammiche A., Fellous T.G., et al. Tracking the cell hierarchy in the human intestine using biochemical signatures derived by mid-infrared microspectroscopy. Stem Cell Res 2009, 3:15-27.
22. Baker M.J., Gazi E., Brown M.D., Shanks J.H., Clarke N.W., Gardner P. Investigating FTIR based histopathology for the diagnosis of prostate cancer. J Biophotonics 2009, 2:104-113.
23. Pijanka J., Sockalingum G.D., Kohler A., et al. Synchrotron-based FTIR spectra of stained single cells. Towards a clinical application in pathology. Lab Invest 2010, 90:787-807. 10.1038/labinvest.2010.8.